ARWR - Arrowhead Pharmaceuticals GAAP EPS of $0.45 beats by $1.06 revenue of $146.26M beats by $100.78M
2023-05-02 17:04:04 ET
- Arrowhead Pharmaceuticals press release ( NASDAQ: ARWR ): Q2 GAAP EPS of $0.45 beats by $1.06 .
- Revenue of $146.26M (-3.6% Y/Y) beats by $100.78M .
For further details see:
Arrowhead Pharmaceuticals GAAP EPS of $0.45 beats by $1.06, revenue of $146.26M beats by $100.78M